Salute e Benessere
Bioinformatics Market to Reach $31.71 Billion by 2031, Driven by Growing Research Activities in Genomics and Rising Need to Develop Novel Drugs/Drug Molecules - Exclusive Report by Meticulous Research®
https://www.meticulousresearch.com/download-sample-report/cp_id=5731
The growth of the biotechnology & pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules are key factors driving the growth of the bioinformatics market. However, the interoperability limitations of bioinformatics analytical platforms due to multiple data types restrain the growth of this market.
Furthermore, emerging economies, the growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture are expected to generate growth opportunities for the players operating in this market. However, data privacy & confidentiality concerns and the shortage of skilled bioinformaticians are major challenges impacting market growth.
Genomic data encompasses various types of information, including DNA sequences, gene expression levels, epigenetic modifications, and protein interactions. Integration of such diverse data makes it difficult to obtain results that can be used for research or diagnostics. Bioinformatics software helps researchers in analyzing and interpreting vast amounts of diverse genomic data. Bioinformatics is used in genomics applications such as genome assembly, functional genomics, comparative genomics, structural genomics, metagenomics, and cancer genomics.
A substantial amount of genomic data is generated every year due to research initiatives and advancements in sequencing technologies. For instance, according to the National Human Genome Research Institute (U.S.), around 40 exabytes of storage will be required to store the genome-sequence data generated worldwide by 2025. Genomic data provides researchers with information about genetics; however, it also presents several challenges in terms of data storage, processing, analysis, and interpretation, driving the demand for bioinformatics.
https://www.meticulousresearch.com/request-sample-report/cp_id=5731
:
https://www.meticulousresearch.com/request-sample-report/cp_id=5731
Based on geography, the bioinformatics market is segmented into North America , Europe , Asia-Pacific , Latin America , and the Middle East & Africa . In 2024, North America is expected to account for the largest share of of the bioinformatics market. The North America bioinformatics market is projected to reach by 2031.
North America's dominant position in the bioinformatics market is attributed to government initiatives supporting genomics research, the growing applications of genomic research, the declining costs of sequencing, pharmaceutical and biopharmaceutical companies' increasing research investments, and the growing adoption of precision medicine due to increasing cancer prevalence.
In 2024, the U.S. is expected to account for the major share of the bioinformatics market in North America . The country's large market share is mainly attributed to increasing government support and spending aimed at improving the country's genome sequencing infrastructure, rising R&D investments of pharmaceutical & biopharmaceutical companies, and the growing acceptance of personalized medicine and personalized cancer treatments.
Asia-Pacific is projected to register the highest CAGR of % during the forecast period. In 2024, China is expected to account for the largest share of the bioinformatics market in Asia-Pacific . The region is witnessing growth in its biotech and pharmaceutical industries, which is driving the demand for bioinformatics solutions in the field of drug discovery and development. Furthermore, the growing adoption of bioinformatics solutions in Asia-Pacific is driven by the growing number of clinical trials, increasing genomics research activities due to favorable public and private initiatives, the growing use of genetic engineering in the agriculture sector, and favorable initiatives supporting the adoption and development of novel bioinformatic tools. For instance, in January 2023 , Pacific Biosciences of California , Inc. (U.S) collaborated with the University of Tokyo , Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods to gain a better understanding of genetic causes of certain rare diseases in the Japanese population.
Initiatives are being undertaken to advance genomics and genetics research in Asia-Pacific , supporting the adoption of bioinformatics solutions in the region. For instance, in 2021, Illumina, Inc. (U.S.) and Sequoia Capital ( China ) launched Sequoia Capital China Intelligent Healthcare Genomics Incubator, powered by Illumina, Inc. (U.S.). The focus of this company is to support start-ups in the country to make advancements in genomics.
https://www.meticulousresearch.com/request-customization/cp_id=5731
In 2024, Germany is expected to account for the largest share of the bioinformatics market in Europe . Factors such as the increasing number of sequencing projects, the rising prevalence of cancer, and growing research for the development of biopharmaceuticals contribute to the country's large market share. Germany is one of the world's leading clinical trial and pharmaceutical innovation hubs in Europe . The country is the second-largest exporter of medicinal products and is one of the top pharmaceutical producers worldwide. In response to the global demand for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals. Furthermore, companies in Germany have moved their focus from small-molecule drugs toward the development and production of complex biological compounds that are produced with the help of a multitude of organisms. Biologics account for a considerable share of the pharmaceutical market in Germany due to their high therapeutic potential.
This report offers a competitive analysis based on an extensive assessment of the leading players' product portfolios, geographic presence, and key growth strategies adopted over the past 3–4 years. Major companies in the bioinformatics market have implemented various strategies to expand their product offerings and global footprints and augment their market shares. The key strategies followed by leading companies in the bioinformatics market include product launches, expansions, mergers & acquisitions, agreements, collaborations, and partnerships. The key players operating in the bioinformatics market include
https://www.meticulousresearch.com/product/bioinformatics-market-5731
The report provides a competitive dashboard summarizing the market positionings of the 22 profiled market players in four quadrants, namely Industry Leaders, Differentiators, Emerging Companies, and Vanguards. These companies are positioned based on various parameters, including revenue, depth of offerings, brand equity, geographic presence, innovation, and organic & inorganic growth strategies. Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann–La Roche Ltd. ( Switzerland ), Agilent Technologies, Inc. (U.S.), and Dassault Systemes SE ( France ) are positioned in the industry leaders quadrant.
https://www.meticulousresearch.com/Checkout/13947739
-
https://www.meticulousresearch.com/product/NGS-market-industry-outlook-5957
-
https://www.meticulousresearch.com/product/ngs-informatics-market-3483
https://www.meticulousresearch.com/product/global-proteomics-market-1195
https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040
https://www.meticulousresearch.com/product/asia-pacific-next-generation-sequencing-market-5722
-https://www.meticulousresearch.com/product/europe-ngs-market-5744
https://www.meticulousresearch.com/product/north-america-ngs-market-5607
https://www.meticulousresearch.com/product/middle-east-and-africa-ngs-market-5786
https://www.meticulousresearch.com/product/latin-america-ngs-market-5780
https://www.meticulousresearch.com/product/algal-pigments-market-5059
https://www.meticulousresearch.com/product/europe-electric-scooter-market-5239
https://www.meticulousresearch.com/product/food-robotics-market-4957
https://www.meticulousresearch.com/product/india-vna-and-pacs-market-4961
https://www.meticulousresearch.com/product/ev-battery-recycling-market-5483
https://www.meticulousresearch.com/product/artificial-casings-market-5035
https://www.meticulousresearch.com/product/wireless-electric-vehicle-charging-systems-market-5178
https://www.meticulousresearch.com/product/natural-food-colors-market-5088
https://www.meticulousresearch.com/product/water-and-wastewater-treatment-market-5026
https://www.meticulousresearch.com/product/europe-plant-based-food-market-5260
https://www.meticulousresearch.com/product/robotic-vacuum-cleaner-market-5181
https://www.meticulousresearch.com/product/algae-products-market-3579
- https://www.meticulousresearch.com/product/industrial-x-ray-inspection-system-market-5148
https://www.meticulousresearch.com/product/language-learning-market-5561
1267 Willis St, Ste 200 Redding,
California , 96001, U.S.
: +1-646-781-8004
: +44-203-868-8738
: +91 744-7780008
Email-
Visit Our Website:
Connect with us on LinkedIn- https://meticulousblog.org/
Content Source: https://www.meticulousresearch.com/pressrelease/965/bioinformatics-market-2031
Photo: https://mma.prnewswire.com/media/2501746/Bioinformatics_Meticulous_Research.jpg
Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bioinformatics-market-to-reach-31-71-billion-by-2031--driven-by-growing-research-activities-in-genomics-and-rising-need-to-develop-novel-drugsdrug-molecules---exclusive-report-by-meticulous-research-302243833.html